Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2003 Nov 01;1406:1045-50. doi: 10.1038/sj.bjp.0705540.
Show Gene links
Show Anatomy links
Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors.
Usala M
,
Thompson SA
,
Whiting PJ
,
Wafford KA
.
???displayArticle.abstract???
1. Investigation into the modulatory effects of chlormethiazole at human recombinant gamma-aminobutyric acid A receptor (GABAA) and N-methyl-d-aspartate (NMDA) receptors was undertaken to gain insight into its mechanism of action and determine if the drug exhibited any subtype-selective activity. 2. Despite a structural similarity to the beta-subunit-selective compound loreclezole, chlormethiazole did not show any difference in maximum efficacy and only a slight difference in EC50 in its potentiating action at alpha1beta1gamma2 and alpha1beta2gamma2 GABAA receptor subtypes with preference for alpha1beta1gamma2. 3. Similar to the previously reported subtype-dependent activity of pentobarbital, chlormethiazole elicited a significantly greater degree of maximum potentiation on receptors lacking a gamma2 subunit, and also those receptors containing an alpha4 or alpha6 subunit. This also demonstrates that chlormethiazole does not act via the benzodiazepine binding site. 4. Unlike pentobarbital and propofol, chlormethiazole elicited only a slight direct GABAA receptor activation at concentrations up to 1 mm. In addition, the drug did not potentiate anaesthetic-mediated currents elicited by pentobarbital or propofol, suggesting that chlormethiazole may be acting via an anaesthetic binding site. 5. Chlormethiazole produced weak nonselective inhibition of human NMDA NR1a+NR2A and NR1a+NR2B receptors. IC50's were approximately 500 microm that likely exceed the therapeutic dose range for chlormethiazole, indicating that the primary mechanism of the compounds in vivo activity is via GABAA receptors.
Addae,
Effects of anticonvulsants on responses to excitatory amino acids applied topically to rat cerebral cortex.
1988, Pubmed
Addae,
Effects of anticonvulsants on responses to excitatory amino acids applied topically to rat cerebral cortex.
1988,
Pubmed
Belelli,
The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors.
1999,
Pubmed
,
Xenbase
Cross,
The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.
1995,
Pubmed
Cross,
The modulation by chlormethiazole of the GABAA-receptor complex in rat brain.
1989,
Pubmed
Fulton,
Intravenous chlormethiazole.
,
Pubmed
Green,
Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.
1998,
Pubmed
Green,
An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its neuroprotective activity.
1998,
Pubmed
Green,
GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke.
2000,
Pubmed
Gustincich,
Composition of the GABA(A) receptors of retinal dopaminergic neurons.
1999,
Pubmed
Hales,
Modulation of GABAA and glycine receptors by chlormethiazole.
1992,
Pubmed
Hara,
Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat.
1993,
Pubmed
Harrison,
Two distinct interactions of barbiturates and chlormethiazole with the GABAA receptor complex in rat cuneate nucleus in vitro.
1983,
Pubmed
Morgan,
The management of alcohol withdrawal using chlormethiazole.
1995,
Pubmed
Nelson,
Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptors.
2002,
Pubmed
Nusser,
Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells.
1998,
Pubmed
Schwartz-Bloom,
gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.
2001,
Pubmed
Slany,
Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors.
1995,
Pubmed
Thompson,
Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
1996,
Pubmed
,
Xenbase
Thompson,
Functional characteristics of recombinant human GABA(A) receptors containing the epsilon-subunit.
1998,
Pubmed
,
Xenbase
Wafford,
Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
1996,
Pubmed
,
Xenbase
Zhong,
Interactions between loreclezole, chlormethiazole and pentobarbitone at GABA(A) receptors: functional and binding studies.
1997,
Pubmed
